Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability
Sponsor: University Hospital, Rouen
Summary
Irritable bowel syndrome (IBS) affects approximately 5% of the general population and remains a daily problem in the practice of clinicians with inconsistent effectiveness of treatments while patients' expectations are high. One of the functional abnormalities described during IBS is increased intestinal permeability. This increase in intestinal permeability is primarily present in the diarrheal subtype (IBS-D) and can be measured using the lactulose/mannitol test. Glutamine is a non-essential amino acid which regulates numerous metabolic pathways, and which plays a key role in the intestine because it is the preferential substrate of enterocytes and immune cells. Ex vivo, glutamine is able to restore the expression of tight junction proteins in patients suffering from IBS-D. On the other hand, glutamine supplementation is capable of reducing abdominal pain and restoring intestinal permeability disorders in a subgroup of patients with intestinal permeability disorder (post-infectious IBS-D). The working hypothesis would be that all patients suffering from IBS with permeability disorder, measured by the lactulose/mannitol test, could benefit from oral glutamine supplementation.
Official title: Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-03
Completion Date
2029-03-01
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
• Experimental group: treatment with glutamine at a dose of 5g 3 times a day for 8 weeks
treatment with glutamine at a dose of 5g 3 times a day for 8 weeks
• Control group: treatment with a protein powder (Protifar) (Placébo) 5g 3 times a day for 8 weeks.
treatment with a protein powder (Protifar) (Placébo) 5g 3 times a day for 8 weeks.
Locations (4)
Chu Amiens
Amiens, France
CHU CAEN
Caen, France
Ch Le Havre
Le Havre, France
Chu Rouen
Rouen, France